The Irish Neurological Association (INA) held its 62nd annual meeting at Clontarf Castle Hotel in Dublin on 14 and 15 May, bringing together neurologists, neuroscientists, trainees and international guests to examine the latest advances in clinical neuroscience and neurological disorders.

Irish Medical Times reported that the two-day conference took place under the presidency of Prof Norman Delanty, consultant neurologist at Beaumont Hospital, and featured presentations across specialisms including epilepsy, neurogenetics, neuroinflammation, autoimmune disorders and neurophysiology.

The keynote Noel Callaghan guest lecture was delivered by Prof Paul Boon, chairman and senior professor of neurology at Ghent University Hospital, who is internationally recognised for his expertise in neurostimulation and neuromodulation for epilepsy and related co-morbid disorders including cognitive decline and depression.

In opening the meeting, Prof Delanty welcomed delegates from neuroscience centres across Ireland, paid tribute to retired colleague Prof Michael Farrell for his contribution to clinical neuroscience in Ireland, and noted that the established practice of having consultants update delegates on new developments in their specialist area would continue.

Michael Crean, deputy executive director of the European Academy of Neurology, also attended as a distinguished guest.

The meeting included presentations from medical students, registrars and specialist registrars, reflecting the association's ongoing commitment to supporting the next generation of neurological practitioners.

A number of prizes were awarded for best presentations, including the Hugh Staunton Prize for the best undergraduate or intern presentation, reinforcing the association's focus on trainee development and research excellence.

The Annual General Meeting of the Irish Institute of Clinical Neuroscience also took place during the conference, chaired by Dr John McConville, IICN dean.

Read the full report on the Irish Neurological Association's 62nd annual meeting and its significance for Irish neuroscience.